My email reply from Jeff Renwick Canntab.Hi Sir.I would like to know if your relationship with the above subject is still a strong prospect into the Australian/Asian market. Thanks Kris. Yes sirVery much so.Jeff RenwickCanntab therapeutics
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game